<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="41%"></col>
<col width="59%"></col>
<tbody>
<tr>
<td stylecode="Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">Interacting Drug</content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">Interaction</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule Botrule " valign="top">
<paragraph>Drugs known to prolong QT interval (e.g., Class IA and Class III antiarrhythmic agents).</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Quinine sulfate prolongs QT interval, ECG abnormalities including QT prolongation and torsade de pointes. Avoid concomitant use (<linkhtml href="#i4i_section_id_045c4f56-bc17-4289-afe7-e4cfc8266352">5.3</linkhtml>).</paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule Botrule " valign="top">
<paragraph>Other antimalarials (e.g., halofantrine, mefloquine).</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>ECG abnormalities including QT prolongation. Avoid concomitant use (<linkhtml href="#i4i_section_id_045c4f56-bc17-4289-afe7-e4cfc8266352">5.3</linkhtml>, <linkhtml href="#i4i_section_id_f1fef4b3-69ed-4800-a0a8-adbb376895b4">7.2</linkhtml>).</paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule Botrule " valign="top">
<paragraph>CYP3A4 inducers or inhibitors</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Alteration in plasma quinine concentration. Monitor for lack of efficacy or increased adverse events of quinine (<linkhtml href="#i4i_section_id_ccff0fde-c21d-4250-a838-691d09fae712">7.1</linkhtml>).</paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule Botrule " valign="top">
<paragraph>CYP3A4 and CYP2D6 substrates</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Quinine is an inhibitor of CYP3A4 and CYP2D6. Monitor for lack of efficacy or increased adverse events of the coadministered drug (<linkhtml href="#i4i_section_id_f1fef4b3-69ed-4800-a0a8-adbb376895b4">7.2</linkhtml>).</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule Lrule " valign="top">
<paragraph>Digoxin</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>Increased digoxin plasma concentration (<linkhtml href="#i4i_section_id_91eb747b-35e0-4097-bb4d-a62b09e9dccd">5.8</linkhtml>, <linkhtml href="#i4i_section_id_ccff0fde-c21d-4250-a838-691d09fae712">7.1</linkhtml>).</paragraph>
</td>
</tr>
</tbody>
</table>